Oxford Nanopore is reportedly eyeing a $2.1bn private placement that could offer an exit to Woodford Investment Management.

Oxford Nanopore, the UK-based genetic sequencing technology spinout of University of Oxford, is to seek £1.6bn ($2.1bn) in a forthcoming private placement, The Times reported yesterday. The purported transaction could help Woodford Investment Management, soon to close having failed to restore its liquidity, by enabling the firm to sell down equity that reportedly represents the…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.